Cyclopropyl 6-[1-[2-(4-chlorophenyl)acetyl]cyclobutyl]-3,4-dihydro-2H-1,5-naphthyridine-1-carboxylate
C24H25ClN2O3 — CID 159733918
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cyclopropyl 6-[1-[2-(4-chlorophenyl)acetyl]cyclobutyl]-3,4-dihydro-2H-1,5-naphthyridine-1-carboxylate
Cyclopropyl 6-[1-[2-(4-chlorophenyl)acetyl]cyclobutyl]-3,4-dihydro-2H-1,5-naphthyridine-1-carboxylate (PubChem CID 159733918) has the molecular formula C24H25ClN2O3 and a molecular weight of 424.93 g/mol. Its IUPAC name is cyclopropyl 6-[1-[2-(4-chlorophenyl)acetyl]cyclobutyl]-3,4-dihydro-2H-1,5-naphthyridine-1-carboxylate.
Molecular Properties
| Compound Name | Cyclopropyl 6-[1-[2-(4-chlorophenyl)acetyl]cyclobutyl]-3,4-dihydro-2H-1,5-naphthyridine-1-carboxylate |
|---|---|
| PubChem CID | 159733918 |
| Molecular Formula | C24H25ClN2O3 |
| Molecular Weight | 424.93 g/mol |
| Exact Mass | 424.16 |
| IUPAC Name | cyclopropyl 6-[1-[2-(4-chlorophenyl)acetyl]cyclobutyl]-3,4-dihydro-2H-1,5-naphthyridine-1-carboxylate |
| SMILES | O=C(OC1CC1)N1CCCc2nc(C3(C(=O)Cc4ccc(Cl)cc4)CCC3)ccc21 |
| InChI | InChI=1S/C24H25ClN2O3/c25-17-6-4-16(5-7-17)15-22(28)24(12-2-13-24)21-11-10-20-19(26-21)3-1-14-27(20)23(29)30-18-8-9-18/h4-7,10-11,18H,1-3,8-9,12-15H2 |
| InChIKey | NBPAIPLYDXYDSI-UHFFFAOYSA-N |
| XLogP | 5.02 |
| TPSA | 59.50 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.93 |
| LogP ≤ 5 | 5.02 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159733918 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.